Vasista, A., Martin, A., Pavlakis, N., Sjoquist, K., Snow, S., Jonker, D., … Kiely, B. (2017). Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer. In ANNALS OF ONCOLOGY (Vol. 28). Madrid, SPAIN: OXFORD UNIV PRESS.

Vasista, A., A. Martin, N. Pavlakis, K. Sjoquist, S. Snow, D. Jonker, Y. J. Chua, et al. “Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer.” In ANNALS OF ONCOLOGY, Vol. 28. OXFORD UNIV PRESS, 2017.

Vasista A, Martin A, Pavlakis N, Sjoquist K, Snow S, Jonker D, et al. Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2017.

Vasista, A., et al. “Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer.” ANNALS OF ONCOLOGY, vol. 28, OXFORD UNIV PRESS, 2017.

Vasista A, Martin A, Pavlakis N, Sjoquist K, Snow S, Jonker D, Chua YJ, Epstein R, Bonaventura A, Khasraw M, Varma SC, Singhal N, Ransom DT, Aubin F, Burkes R, Lim H, Lemay F, Begbie S, Stockler MR, Kiely B. Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2017.